Johnson & Johnson Survey Reveals Major Awareness Gap in…

Event summary

Johnson & Johnson's global survey of 6,000 women aged 35–60 found only 40% connect eye health changes with menopause, despite 90% valuing clear vision for confidence.
66% of respondents reported dry or irritated eyes, and 60% experienced blurred vision, yet only 18% discussed these changes with an eye care professional.
The survey was conducted across six countries (US, UK, Brazil, South Korea, Japan, China) from July 31 to August 6, 2026.
Johnson & Johnson is collaborating with actress Naomi Watts and the American Optometric Association to raise awareness about menopause-related eye health changes.

The big picture

Johnson & Johnson's survey highlights a significant unmet need in menopause care, positioning the company to lead in a growing niche within women's health. The findings underscore the opportunity to integrate eye health into broader menopause management strategies, aligning with the company's ambition to improve sight for millions annually. This initiative could set a precedent for how healthcare providers address midlife vision changes, potentially influencing industry standards and patient expectations.

What we're watching

Awareness Campaign Impact: Whether Johnson & Johnson's collaboration with Naomi Watts and the AOA can effectively bridge the awareness gap about menopause-related eye health changes.
Market Expansion: How the company will leverage these insights to expand its vision care products, particularly for menopausal women.
Regulatory and Industry Trends: The pace at which menopause-related eye health becomes a standard topic in optometric and gynecological consultations.